GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) have been assigned an average recommendation of “Hold” from the fifteen ratings firms that are covering the firm, Marketbeat reports. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $4.7292.

Several research firms have weighed in on GDRX. Wall Street Zen cut GoodRx from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Bank of America reissued a “reduce” rating on shares of GoodRx in a research note on Monday, January 5th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of GoodRx in a research note on Tuesday, December 23rd. UBS Group lowered their price target on GoodRx from $4.25 to $4.00 and set a “neutral” rating for the company in a research note on Thursday, November 6th. Finally, TD Cowen dropped their price objective on GoodRx from $7.00 to $6.00 and set a “buy” rating on the stock in a report on Monday, November 10th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of GDRX. Meridian Wealth Management LLC acquired a new stake in shares of GoodRx in the 4th quarter valued at $29,000. Quarry LP bought a new position in GoodRx during the third quarter valued at about $33,000. MML Investors Services LLC acquired a new stake in shares of GoodRx in the fourth quarter worth about $36,000. DRW Securities LLC bought a new stake in shares of GoodRx during the 4th quarter worth about $40,000. Finally, Boothbay Fund Management LLC bought a new stake in shares of GoodRx during the 3rd quarter worth about $43,000. Institutional investors own 63.77% of the company’s stock.

GoodRx Stock Performance

Shares of GDRX stock opened at $2.37 on Friday. The company has a market capitalization of $804.46 million, a price-to-earnings ratio of 26.33, a P/E/G ratio of 0.86 and a beta of 1.50. GoodRx has a 1-year low of $2.10 and a 1-year high of $5.81. The company has a current ratio of 3.11, a quick ratio of 3.11 and a debt-to-equity ratio of 0.81. The stock’s fifty day simple moving average is $2.55 and its 200-day simple moving average is $3.29.

GoodRx Company Profile

GoodRx Holdings, Inc (NASDAQ: GDRX) operates a digital healthcare platform designed to help consumers compare prescription drug prices at retail pharmacies across the United States. Through its website and mobile applications, GoodRx aggregates pricing and discount information from a wide network of pharmacies, enabling users to access coupons and savings programs on both generic and brand-name medications. The platform also features price transparency tools that inform patients about cost variations and available discounts to alleviate the financial burden of prescription medications.

In addition to its core drug pricing service, GoodRx offers telehealth services under the GoodRx Care brand, providing virtual consultations for a range of non-emergency conditions and prescription needs.